LBP and inflammation: For example, LPS, a pathogen-associated molecular pattern, usually does not enter the bloodstream, but while integrity of the gut barrier is compromised, LPS can enter the portal vein by combining with LPS-binding protein (LBP), thereby activating hepatic inflammasomes and ultimately leading to liver inflammation and fibrosis [47, 48].